Radius Health, Inc. (RDUS)
Total Valuation
Radius Health has a market cap or net worth of $488.86 million. The enterprise value is $756.82 million.
| Market Cap | 488.86M |
| Enterprise Value | 756.82M |
Important Dates
The next earnings date is Thursday, August 4, 2022, before market open.
| Estimated Earnings Date | Aug 4, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
Radius Health has 47.60 million shares outstanding. The number of shares has increased by 0.98% in one year.
| Shares Outstanding | 47.60M |
| Shares Change (YoY) | +0.98% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 117.14% |
| Float | 40.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 16.16 |
| PS Ratio | 2.25 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of n/a.
| Current Ratio | 1.81 |
| Quick Ratio | 1.27 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -40.70% |
| Return on Capital (ROIC) | -16.50% |
| Revenue Per Employee | $740,174 |
| Profits Per Employee | -$248,133 |
| Employee Count | 293 |
| Asset Turnover | 1.21 |
| Inventory Turnover | 1.70 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.92% in the last 52 weeks. The beta is 1.03, so Radius Health's price volatility has been similar to the market average.
| Beta (1Y) | 1.03 |
| 52-Week Price Change | -45.92% |
| 50-Day Moving Average | 7.14 |
| 200-Day Moving Average | 7.41 |
| Average Volume (30 Days) | 1,145,853 |
Short Selling Information
The latest short interest is 8.38 million, so 17.60% of the outstanding shares have been sold short.
| Short Interest | 8.38M |
| Short % of Shares Out | 17.60% |
| Short % of Float | 20.79% |
| Short Ratio (days to cover) | 9.06 |
Income Statement
In the last 12 months, Radius Health had revenue of $216.87 million and -72.70 million in losses. Earnings per share was -$1.54.
| Revenue | 216.87M |
| Gross Profit | 197.59M |
| Operating Income | -54.76M |
| Net Income | -72.70M |
| EBITDA | -52.69M |
| EBIT | -53.99M |
| Earnings Per Share (EPS) | -$1.54 |
Balance Sheet
The company has $72.18 million in cash and $340.14 million in debt, giving a net cash position of -$267.96 million or -$5.63 per share.
| Cash & Cash Equivalents | 72.18M |
| Total Debt | 340.14M |
| Net Cash | -267.96M |
| Net Cash Per Share | -$5.63 |
| Book Value | -265.95M |
| Book Value Per Share | -5.59 |
| Working Capital | 65.31M |
Cash Flow
In the last 12 months, operating cash flow was -$43.56 million and capital expenditures -$185,000, giving a free cash flow of -$43.75 million.
| Operating Cash Flow | -43.56M |
| Capital Expenditures | -185,000 |
| Free Cash Flow | -43.75M |
| FCF Per Share | n/a |
Margins
Gross margin is 91.11%, with operating and profit margins of -25.25% and -33.52%.
| Gross Margin | 91.11% |
| Operating Margin | -25.25% |
| Pretax Margin | n/a |
| Profit Margin | -33.52% |
| EBITDA Margin | -24.30% |
| EBIT Margin | -24.89% |
| FCF Margin | -20.17% |
Dividends & Yields
Radius Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -14.87% |
| FCF Yield | -8.95% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.98% |
| Shareholder Yield | -0.98% |
Analyst Forecast
The average price target for Radius Health is $8.84, which is -13.92% lower than the current price. The consensus rating is "Sell".
| Price Target | $8.84 |
| Price Target Difference | -13.92% |
| Analyst Consensus | Sell |
| Analyst Count | 13 |
Stock Splits
The last stock split was on April 24, 2014. It was a reverse split with a ratio of 25:57.
| Last Split Date | Apr 24, 2014 |
| Split Type | Reverse |
| Split Ratio | 25:57 |